Thanks for replying Mr Worzel, I always enjoy your analysis
How do you figure that? I have the two companies' current market caps around ~A$100m more than the value of their gold on hand (at 30Jun16). If I add say 55k ounces between the two companies for July-December, and then sell 75% of that to cover expenses, I'm still short by about $87m or so?
That's what I was trying to do, but I can only go off what's in the balance sheet of the annual report. What makes you say they're consolidated figures? Are there other sources of information I can be using?
So where in the balance sheet do TBR account for their $44m stake in RND? And where does RND account for their $69m stake in TBR? Seems like a pretty glaring omission to me..!
I respectfully disagree. If Company A has $50m of cash and owns half of Company B, and Company B has $50m of cash and owns half of company A, what are the market values of each company? The answer is $100m each, which means the total market caps of A and B are $200m, even though only $100m of real assets exist in the real world. It's absurd, I know.
$320m of gold? Have you added ~55k ounces for the July-December period? If yes, remember TBR seem to sell about ~75% of incoming gold to cover expenses (I'm actually not 100% sure on this amount - do you have a figure for the gold sold vs. gold hoarded?).
Aside from the exact figures, I completely agree. They have a mountain of gold and excellent mine which together are worth more than half a billion, and an expectation of further income that means TBR should be over $10/share. Old mate Billis needs to do a roadshow or something and wake up the country's investors haha
- Forums
- ASX - By Stock
- TBR
- Valuing TBR and RND without their crossholdings
Valuing TBR and RND without their crossholdings, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TBR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.90 |
Change
-0.030(0.61%) |
Mkt cap ! $230.8M |
Open | High | Low | Value | Volume |
$4.93 | $4.93 | $4.90 | $61.74K | 12.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2356 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.88 | 1072 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | 4.850 |
1 | 2079 | 4.800 |
2 | 2250 | 4.600 |
1 | 538 | 4.500 |
1 | 550 | 4.310 |
Price($) | Vol. | No. |
---|---|---|
4.960 | 1 | 1 |
4.970 | 2 | 1 |
5.120 | 1000 | 1 |
5.200 | 200 | 1 |
5.500 | 100 | 1 |
Last trade - 10.54am 25/11/2024 (20 minute delay) ? |
Featured News
TBR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online